When a hospital operator like Tenet posts results strong enough to send its stock up 16% in a single session, it signals something positive is happening across the hospital industry — whether that's patient volume, pricing, or cost control. HCA is the lar

Verdict: Wait for HCA's RSI to Cool Below 70

This is a legitimate sector-rotation idea — Tenet's 16% single-session surge on July 24 is the kind of catalyst that can pull capital into lagging peers, and HCA's $7.7B in trailing free cash flow (99th percentile) plus 28.8% EPS growth give it the fundamental capacity to participate. But the strategy's own rules block entry today: HCA's RSI sits at 75.3, above the 70 entry ceiling, and one of the two exit conditions (RSI above 75) is already marginally live at just 0.33 points over the threshold. The deeper problem is a 42.5% win rate across 160 trades with a 14.7% maximum drawdown, and the reward-to-risk of a 4.7% take-profit against a 2.3% stop is uncomfortably tight in a sector where Tenet just moved 16% in a session — meaning exits may trigger on noise before the rotation thesis matures. This setup is worth watching for an RSI cooldown back below 70 paired with an EMA cross, but it is not worth taking at current levels. **Conviction breakdown** - **Thesis support (55/100):** The Barron's-cited Tenet catalyst is real and HCA's fundamentals are strong, but THC's 52.6% EPS contraction and 3.1% revenue growth (versus HCA's 7.1%) suggest the two names may not share a uniform tailwind. - **Trade readiness (25/100):** The strategy requires HCA's RSI below 70; it currently sits at 75.3, making the setup unactionable and already partially triggering an exit condition. - **Risk quality (35/100):** A 2.3% stop against 4.7% take-profit is vulnerable to being stopped out by normal sector volatility, and the risk-parity basket projects a 50.5% expected maximum drawdown. - **Backtest evidence (45/100):** The 60-month backtest produced a 13.8% return, but the 42.5% win rate means losses outnumber wins; the 24-month sub-window (25.0% return, 10.7% drawdown) is encouraging but thin at just 10 trades. - **Fundamentals trend (60/100):** HCA's free cash flow and EPS growth are elite, but revenue growth in just the 35th percentile of Health Care peers and a structurally negative equity base of negative $6.0B temper conviction.

Trade now

The setup is not actionable today — the entry rules require HCA's RSI (14) to be **below 70**, but it currently sits at 75.3, which means the condition is 5.3 points over the threshold. Meanwhile, the EMA (9) at 391.53 is just 2.6 points above the EMA (21) at 388.92, flagged as near but not yet crossed above. ADX at 68.2 is well above the 20 floor, and the RSI-above-50 condition is satisfied at 25.3 points of margin. The core blocker is overbought momentum: the strategy wants to buy on a trend-confirmed pullback that stays below 70, and the market has already pushed past that. HCA closed at $412.61. The strategy's stop-loss sits at the first support level of $411 — just 0.4% below the current close — and the hard stop fires at a 2.3% loss, implying an effective floor around $403. The take-profit exits are layered: a fixed 4.7% gain triggers near $432, and the 127.2% Fibonacci extension offers a further upside target. With the nearest resistance at $421.44, the immediate reward-to-risk from current levels is unfavorable given how close price is to support. "Wait" means precisely this: do not enter until RSI cools back below 70 and the nine-day EMA crosses above the 21-day EMA from below — both must be true on a daily close. The backtested evidence supports patience. Over the 60-month evaluation window the strategy produced 160 trades on HCA with a 42.5% win rate, a 13.8% cumulative return, and a 14.7% maximum drawdown. The more recent 24-month window was stronger — 10 trades, a 25.0% return, and a shallower 10.7% drawdown — but exits were filled on daily bars rather than intrabar data, so reported fill quality is coarse. No parameter-sensitivity recommendation was established; the optimizer exceeded its time budget without producing a nearby-variant result. The idea's thesis — that Tenet's 16% single-session surge signals sector-wide strength and money managers will rotate into HCA as a lagging peer — is directionally consistent with today's momentum readings. But the strategy's own rules are designed to avoid chasing exactly this kind of overbought move. The trigger to watch for is a cooldown, not a continuation.

The hospital recovery trade has real fundamental and quantitative support

The idea argues that when one hospital operator like Tenet posts blowout results, money rotates into direct peers like HCA within days. The Barron's piece on July 24, 2026 confirms the triggering event: Tenet's stock surged 16% in a single session while HCA lagged behind. That sets up a classic sector-rotation trade where the largest for-profit hospital chain in the country catches up to…

Scores

• Conviction score breakdown: 44
• Thesis support: 55
• Trade readiness: 25
• Risk quality: 35
• Backtest evidence: 45
• Fundamentals trend: 60

Watch items

• HCA — RSI (14)
• HCA — EMA (9) vs EMA (21)
• HCA — RSI (14) — exit signal
• HCA — Price vs Support[1]
• THC — RSI (14)
• HCA — EMA (9) crossed above EMA (21)
• HCA — RSI (14) above 50
• HCA — RSI (14) below 70
• HCA — ADX (14) above 20